Department of Animal Biology and Physiology, Laboratory of Animal Physiology, University of Yaounde I, Yaounde, Cameroon.
Fitoterapia. 2011 Oct;82(7):939-49. doi: 10.1016/j.fitote.2011.05.009. Epub 2011 May 23.
To determine whether the two major compounds of Erythrina lysistemon are active principles accounting for Erythrina estrogenic effects, we used a postmenopause-like model of ovariectomized Wistar rats to evaluate their effects on some menopausal problems. Ovariectomized rats were orally treated either with compound 1 or compound 2 at 1 and 10 mg/kg BW for 28 days. Estradiol valerate served as the reference substance. As results, compounds 1 and 2 displayed estrogen-like effects on the uterus and the vagina, and reduced atherogenic risks by decreasing the two assessed atherogenic parameters, the total cholesterol/HDL-cholesterol ratio and the atherogenic index of plasma.
为了确定仪花中的两种主要化合物是否为具有雌激素样作用的活性成分,我们采用去卵巢 Wistar 大鼠绝经后模型来评价它们对某些绝经后问题的作用。用 1 和 10 mg/kg BW 的化合物 1 和化合物 2 对去卵巢大鼠进行 28 天的口服处理。戊酸雌二醇作为参比物质。结果表明,化合物 1 和化合物 2 对子宫和阴道具有雌激素样作用,并通过降低两个评估的动脉粥样硬化参数(总胆固醇/高密度脂蛋白胆固醇比值和血浆致动脉粥样硬化指数)来降低动脉粥样硬化风险。